82 FR 41054 - Bulk Manufacturer of Controlled Substances Application: Cody Laboratories, Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 82, Issue 166 (August 29, 2017)
Drug Enforcement Administration
Federal Register Volume 82, Issue 166 (August 29, 2017)
| Page Range | 41054-41054 | |
| FR Document | 2017-18316 |
[Federal Register Volume 82, Number 166 (Tuesday, August 29, 2017)] [Notices] [Page 41054] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-18316] [[Page 41054]] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Cody Laboratories, Inc. ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before October 30, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on June 12, 2017, Cody Laboratories, Inc., Steve Hartman, VP Compliance, 601 Yellowstone Avenue, Cody, Wyoming 82414 applied to be registered as a bulk manufacturer the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ Dihydromorphine.................... 9145 I Amphetamine........................ 1100 II Methamphetamine.................... 1105 II Lisdexamfetamine................... 1205 II Methylphenidate.................... 1724 II Amobarbital........................ 2125 II Pentobarbital...................... 2270 II Secobarbital....................... 2315 II 4-Anilino-N-phenethyl-4-piperidine 8333 II (ANPP). Cocaine............................ 9041 II Codeine............................ 9050 II Dihydrocodeine..................... 9120 II Oxycodone.......................... 9143 II Hydromorphone...................... 9150 II Diphenoxylate...................... 9170 II Ecgonine........................... 9180 II Hydrocodone........................ 9193 II Meperidine......................... 9230 II Methadone.......................... 9250 II Methadone intermediate............. 9254 II Morphine........................... 9300 II Thebaine........................... 9333 II Oxymorphone........................ 9652 II Alfentanil......................... 9737 II Remifentanil....................... 9739 II Sufentanil......................... 9740 II Tapentadol......................... 9780 II Fentanyl........................... 9801 II ------------------------------------------------------------------------ The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Dated: August 21, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017-18316 Filed 8-28-17; 8:45 am] BILLING CODE 4410-09-P
![41054 Federal Register / Vol. 82, No. 166 / Tuesday, August 29, 2017 / Notices
DEPARTMENT OF JUSTICE ADDRESSES: Written comments should importers, and exporters of controlled
be sent to: Drug Enforcement substances (other than final orders in
Drug Enforcement Administration Administration, Attention: DEA Federal connection with suspension, denial, or
[Docket No. DEA–392] Register Representative/DRW, 8701 revocation of registration) has been
Morrissette Drive, Springfield, Virginia redelegated to the Assistant
Bulk Manufacturer of Controlled 22152. Administrator of the DEA Diversion
Substances Application: Cody Control Division (‘‘Assistant
SUPPLEMENTARY INFORMATION: The
Laboratories, Inc. Administrator’’) pursuant to section 7 of
Attorney General has delegated his
28 CFR part 0, appendix to subpart R.
ACTION: Notice of application. authority under the Controlled
Substances Act to the Administrator of In accordance with 21 CFR
DATES: Registered bulk manufacturers of the Drug Enforcement Administration 1301.33(a), this is notice that on June
the affected basic classes, and (DEA), 28 CFR 0.100(b). Authority to 12, 2017, Cody Laboratories, Inc., Steve
applicants therefore, may file written exercise all necessary functions with Hartman, VP Compliance, 601
comments on or objections to the respect to the promulgation and Yellowstone Avenue, Cody, Wyoming
issuance of the proposed registration in implementation of 21 CFR part 1301, 82414 applied to be registered as a bulk
accordance with 21 CFR 1301.33(a) on incident to the registration of manufacturer the following basic classes
or before October 30, 2017. manufacturers, distributors, dispensers, of controlled substances:
Controlled substance Drug code Schedule
Dihydromorphine ............................................................................................................................................................. 9145 I
Amphetamine ................................................................................................................................................................... 1100 II
Methamphetamine ........................................................................................................................................................... 1105 II
Lisdexamfetamine ............................................................................................................................................................ 1205 II
Methylphenidate .............................................................................................................................................................. 1724 II
Amobarbital ...................................................................................................................................................................... 2125 II
Pentobarbital .................................................................................................................................................................... 2270 II
Secobarbital ..................................................................................................................................................................... 2315 II
4-Anilino-N-phenethyl-4-piperidine (ANPP) ..................................................................................................................... 8333 II
Cocaine ............................................................................................................................................................................ 9041 II
Codeine ........................................................................................................................................................................... 9050 II
Dihydrocodeine ................................................................................................................................................................ 9120 II
Oxycodone ....................................................................................................................................................................... 9143 II
Hydromorphone ............................................................................................................................................................... 9150 II
Diphenoxylate .................................................................................................................................................................. 9170 II
Ecgonine .......................................................................................................................................................................... 9180 II
Hydrocodone ................................................................................................................................................................... 9193 II
Meperidine ....................................................................................................................................................................... 9230 II
Methadone ....................................................................................................................................................................... 9250 II
Methadone intermediate .................................................................................................................................................. 9254 II
Morphine .......................................................................................................................................................................... 9300 II
Thebaine .......................................................................................................................................................................... 9333 II
Oxymorphone .................................................................................................................................................................. 9652 II
Alfentanil .......................................................................................................................................................................... 9737 II
Remifentanil ..................................................................................................................................................................... 9739 II
Sufentanil ......................................................................................................................................................................... 9740 II
Tapentadol ....................................................................................................................................................................... 9780 II
Fentanyl ........................................................................................................................................................................... 9801 II
The company plans to manufacture DATES: Registered bulk manufacturers of Virginia 22152. All request for hearing
the listed controlled substances in bulk the affected basic classes, and should also be sent to: (1) Drug
for distribution to its customers. applicants therefore, may file written Enforcement Administration, Attn:
Dated: August 21, 2017. comments on or objections to the Hearing Clerk/LJ, 8701 Morrissette
Demetra Ashley,
issuance of the proposed registration in Drive, Springfield, Virginia 22152; and
accordance with 21 CFR 1301.34(a) on (2) Drug Enforcement Administration,
Acting Assistant Administrator.
or before September 28, 2017. Such Attn: DEA Federal Register
[FR Doc. 2017–18316 Filed 8–28–17; 8:45 am]
persons may also file a written request Representative/DRW, 8701 Morrissette
BILLING CODE 4410–09–P for a hearing on the application Drive, Springfield, Virginia 22152.
pursuant to 21 CFR 1301.43 on or before Comments and requests for hearing on
September 28, 2017. applications to import narcotic raw
DEPARTMENT OF JUSTICE
ADDRESSES: Written comments should material are not appropriate. 72 FR 3417
Drug Enforcement Administration be sent to: Drug Enforcement (January 25, 2007).
sradovich on DSK3GMQ082PROD with NOTICES
Administration, Attention: DEA Federal SUPPLEMENTARY INFORMATION: The
[Docket No. DEA–392] Register Representative/DRW, 8701 Attorney General has delegated his
Morrissette Drive, Springfield, Virginia authority under the Controlled
Importer of Controlled Substances 22152. All requests for hearing must be Substances Act to the Administrator of
Application: Stepan Company sent to: Drug Enforcement the Drug Enforcement Administration
Administration, Attn: Administrator, (DEA), 28 CFR 0.100(b). Authority to
ACTION: Notice of application.
8701 Morrissette Drive, Springfield, exercise all necessary functions with
VerDate Sep<11>2014 18:45 Aug 28, 2017 Jkt 241001 PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 E:\FR\FM\29AUN1.SGM 29AUN1](https://thefederalregister.org/doc/82_FR_41220/page/1.svg)
Document Created: 2017-08-29 01:58:22
Document Modified: 2017-08-29 01:58:22
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before October 30, 2017. | |
| FR Citation | 82 FR 41054 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR